TRAX — First Tracks Biotherapeutics Cashflow Statement
0.000.00%
Last trade - 00:00- $619.22m
- $619.22m
Annual cashflow statement for First Tracks Biotherapeutics, fiscal year end - December 31st, USD millions except per share, conversion factor applied.
2024 December 31st | 2025 December 31st | |
|---|---|---|
| Period Length: | 12 M | 12 M |
| Source: | PROSPECTUS | PROSPECTUS |
| Standards: | USG | USG |
| Status: | Final | Final |
| Net Income/Starting Line | -164 | -166 |
| Depreciation | ||
| Non-Cash Items | 18.3 | 29.4 |
| Unusual Items | ||
| Other Non-Cash Items | ||
| Changes in Working Capital | 19 | -6.83 |
| Change in Prepaid Expenses | ||
| Change in Accrued Expenses | ||
| Change in Payable / Accrued Expenses | ||
| Cash from Operating Activities | -126 | -143 |
| Capital Expenditures | -0.358 | -0.087 |
| Purchase of Fixed Assets | ||
| Other Investing Cash Flow Items | 95.8 | 228 |
| Sale/Maturity of Investment | ||
| Purchase of Investments | ||
| Cash from Investing Activities | 95.4 | 228 |
| Net Issuance / Retirement of Stock | ||
| Cash from Financing Activities | 118 | 30 |
| Beginning Cash Balance | ||
| Ending Cash Balance | ||
| Net Change in Cash | 87.1 | 115 |